• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing (NY: ASX )

10.00 +0.09 (+0.91%)
Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,321,117
Open 9.810
Bid (Size) 10.00 (1)
Ask (Size) 10.46 (18)
Prev. Close 9.910
Today's Range 9.810 - 10.13
52wk Range 8.100 - 12.86
Shares Outstanding 4,408,018,732
Dividend Yield 3.22%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Precious Metals & Critical Materials Virtual Investor Conference: Presentations Now Available for Online Viewing
December 12, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
American Rare Earths to Present at the Precious Metals & Critical Materials Virtual Investor Conference December 11th
December 06, 2024
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire

Performance

YTD
+10.13%
+10.13%
1 Month
+1.94%
+1.94%
3 Month
N/A
N/A
6 Month
-12.20%
-12.20%
1 Year
+9.17%
+9.17%

More News

Read More
Earnings Outlook For ASE Tech Holding Co
October 30, 2024
Via Benzinga
Precious Metals & Critical Materials Virtual Investor Conference Agenda Announced for December 10th and 11th
December 09, 2024
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Completes Last Patient Visit in ATH434-201 Phase 2 Clinical Trial in Early-Stage Multiple System Atrophy
December 04, 2024
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th
December 03, 2024
From Virtual Investor Conferences
Via GlobeNewswire
Life360 Named One of the Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500™
November 21, 2024
From Life360, Inc.
Via GlobeNewswire
Alterity Therapeutics Appoints Abby Macnish Niven as Company Secretary
November 19, 2024
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Life360 Reports Record Q3 2024 Results
November 12, 2024
From Life360, Inc.
Via GlobeNewswire
Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium
November 12, 2024
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
ISE Labs Investment Secures the Establishment of New Site for Semiconductor Packaging and Test in Mexico
November 07, 2024
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434
November 06, 2024
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Appendix 4C – Q1 FY25 Quarterly Cash Flow Report
October 31, 2024
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
ASE “Guardians of the Sea” Wins Gold at the PwC Sustainability Impact Awards
October 25, 2024
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy
October 17, 2024
From Travere Therapeutics, Inc.
Via GlobeNewswire
Cogstate Expands Alzheimer's Disease Leadership with Appointment of Dr. Kaycee Sink, as Chief Medical Officer
October 14, 2024
From Cogstate Ltd.
Via GlobeNewswire
Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024
October 14, 2024
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting
October 11, 2024
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
ATHA Energy Announces Option Agreements With Terra Uranium for Spire, Horizon, and Pasfield Projects
October 11, 2024
From ATHA Energy Corp.
Via GlobeNewswire
Majority Of Taiwanese Citizens Downplay Invasion Threat From China Within Next 5 Years: Here Is How TSMC, UMC And Others Would Be Impacted
October 09, 2024
Via Benzinga
Small Cap Growth Virtual Investor Conference Agenda Announced for October 10th
October 07, 2024
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
October 02, 2024
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Novo Resources to Present at the Battery and Precious Metals Virtual Investor Conference October
September 30, 2024
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
September 30, 2024
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
September 23, 2024
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap